INTERPACE BIOSCIENCES, INC. (IDXG) Gross margin 2016–2025
INTERPACE BIOSCIENCES, INC. (IDXG) gross margin by fiscal year — reported gross profit divided by reported revenue.
62.3%FY2025 · since FY2016: 49.2% → 62.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 62.3% | -1.5 pp |
| FY2024 | 63.8% | +1.2 pp |
| FY2023 | 62.6% | +5.3 pp |
| FY2022 | 57.3% | +0.5 pp |
| FY2021 | 56.8% | +23.7 pp |
| FY2020 | 33.1% | -1.3 pp |
| FY2019 | 34.4% | -19.0 pp |
| FY2018 | 53.4% | -0.3 pp |
| FY2017 | 53.7% | +4.5 pp |
| FY2016 | 49.2% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice